Skip to main content

AKM LINEZOLID, PHARMACOR LINEZOLID (Pharmacor Pty Ltd)

Product name
AKM LINEZOLID, PHARMACOR LINEZOLID
Date registered
Evaluation commenced
Decision date
Approval time
96 working days (255)
Active ingredients
Linezolid
Registration type
New generic medicine
Indication
AKM LINEZOLID, PHARMACOR LINEZOLID (tablets) is indicated for the treatment of suspected or proven infections due to Gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant Staphylococcus species and vancomycin resistant Enterococcus species.

Help us improve the Therapeutic Goods Administration site